Mathias Svahn has extended his valuable service in Karolinska Institutet as Scientific Manager and has been a recipient of many award and grants. Currently, he is working as CEO for NextCell Pharma. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Stem cell technology, next generation of stem cell therapy.